Seidenstein v. National Medical Enterprises, Inc.’s Empirical Analysis
769 F.2d 1100 · 1985
Citation profile
15 federal appellate · 3 district · 2 state decisions
How this case has been cited
Cited by 37 later decisions — most recently January 2021 · most notably Brader v. Allegheny General Hospital (1995), Doctor's Hospital of Jefferson, Inc. v. Southeast Medical Alliance, Inc. (1997)
15 federal appellate · 3 district · 2 state decisions
Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.
Relationships
Applies 15 U.S.C. § 2 (§ 2 of the Sherman Antitrust Act)
Relies on New York Times Co. v. Sullivan · Gertz v. Robert Welch, Inc. · United States v. Grinnell Corp. · Bose Corp. v. Consumers Union of United States, Inc. · St. Amant v. Thompson
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 37 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“absent exceptional market conditions, one brand in a market of competing brands cannot constitute a relevant product market.”
1 later decision quote this exact passage · from the majority“Proof of falsity in fact is not enough, nor is proof of a combination of falsehood and general hostility.”
1 later decision quote this exact passage · from the majority“Before a defendant's market power can be determined, the relevant market must be defined.”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.